InsiderTrades

Form 4 for IDXX Idexx Laboratories

Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-08 · accession 0000874716-25-000135 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-12 2025-08-08+ IDXX Underberg Sharon E. EVP, GC, Corp. Sec M - OptEx $217.89 +5,633 6,339 +798% +$1.23M
D 2025-08-12 2025-08-08 IDXX Underberg Sharon E. EVP, GC, Corp. Sec S - Sale+OE $651.60 -5,450 6,156 -47% -$3.55M
DM 2025-08-12 2025-08-08+ IDXX Underberg Sharon E. EVP, GC, Corp. Sec M - OptEx $0.00 -5,633 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-08 M A 5,450 $206.94 11,605.65 D — — (F1) Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
2 Common Common Stock 2025-08-08 S D 5,450 $651.60 6,155.65 D — —
3 Common Common Stock 2025-08-12 M A 183 $544.08 6,338.65 D — —
4 Derivative Non-Qualified Stock Option (right-to-buy) 2025-08-08 M D 5,450 $0.00 0 D $206.94 · — to 2029-02-13 5,450 Common Stock (F2) Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning on February 14, 2020.
5 Derivative Incentive Stock Option (right-to-buy) 2025-08-12 M D 183 $0.00 0 D $544.08 · — to 2031-02-13 183 Common Stock (F3) Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.